Noah Benjamin

Person

San Francisco, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
JAK kinase inhibitor compounds for treatment of respiratory disease
- Patent number 11,718,616
- Issue date Aug 8, 2023
- Theravance Biopharma R&D IP, LLC
- Paul R. Fatheree
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods for enriching alpha-tocotrienol from mixed tocol compositions
- Patent number 11,560,364
- Issue date Jan 24, 2023
- PTC Therapeutics, Inc.
- Peter Giannousis
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods for enriching alpha-tocotrienol from mixed tocol compositions
- Patent number 11,186,559
- Issue date Nov 30, 2021
- PTC Therapeutics, Inc.
- Peter Giannousis
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
JAK kinase inhibitor compounds for treatment of respiratory disease
- Patent number 10,913,740
- Issue date Feb 9, 2021
- Theravance Biopharma R&D IP, LLC
- Paul R. Fatheree
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods for enriching alpha-tocotrienol from mixed tocol compositions
- Patent number 10,745,371
- Issue date Aug 18, 2020
- PTC Therapeutics, Inc.
- Peter Giannousis
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
JAK kinase inhibitor compounds for treatment of respiratory disease
- Patent number 10,183,942
- Issue date Jan 22, 2019
- Theravance Biopharma R&D IP, LLC
- Noah Benjamin
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
JAK KINASE INHIBITOR COMPOUNDS FOR TREATMENT OF RESPIRATORY DISEASE
- Publication number 20220306624
- Publication date Sep 29, 2022
- THERAVANCE BIOPHARMA R&D IP, LLC
- Paul R. Fatheree
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS FOR ENRICHING ALPHA-TOCOTRIENOL FROM MIXED TOCOL COMPOSITIONS
- Publication number 20220048880
- Publication date Feb 17, 2022
- PTC THERAPEUTICS, INC.
- Peter GIANNOUSIS
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS FOR ENRICHING ALPHA-TOCOTRIENOL FROM MIXED TOCOL COMPOSITIONS
- Publication number 20200377468
- Publication date Dec 3, 2020
- PTC THERAPEUTICS, INC.
- Peter GIANNOUSIS
- C07 - ORGANIC CHEMISTRY
Information Patent Application
JAK Kinase Inhibitor Compounds for Treatment of Respiratory Disease
- Publication number 20200087303
- Publication date Mar 19, 2020
- THERAVANCE BIOPHARMA R&D IP, LLC
- Paul R. Fatheree
- C07 - ORGANIC CHEMISTRY
Information Patent Application
JAK Kinase Inhibitor Compounds for Treatment of Respiratory Disease
- Publication number 20180319796
- Publication date Nov 8, 2018
- THERAVANCE BIOPHARMA R&D IP, LLC
- Noah Benjamin
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FUSED IMIDAZO-PIPERIDINE JAK INHIBITOR COMPOUND
- Publication number 20180311255
- Publication date Nov 1, 2018
- THERAVANCE BIOPHARMA R&D IP, LLC
- PAUL R. FATHEREE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
JAK Kinase Inhibitor Compounds for Treatment of Respiratory Disease
- Publication number 20170121327
- Publication date May 4, 2017
- THERAVANCE BIOPHARMA R&D IP, LLC
- Paul R. Fatheree
- C07 - ORGANIC CHEMISTRY

Noah Benjamin

Person

Patents Grantslast 30 patents

JAK kinase inhibitor compounds for treatment of respiratory disease

Methods for enriching alpha-tocotrienol from mixed tocol compositions

Methods for enriching alpha-tocotrienol from mixed tocol compositions

JAK kinase inhibitor compounds for treatment of respiratory disease

Methods for enriching alpha-tocotrienol from mixed tocol compositions

JAK kinase inhibitor compounds for treatment of respiratory disease

Patents Applicationslast 30 patents

JAK KINASE INHIBITOR COMPOUNDS FOR TREATMENT OF RESPIRATORY DISEASE

METHODS FOR ENRICHING ALPHA-TOCOTRIENOL FROM MIXED TOCOL COMPOSITIONS

METHODS FOR ENRICHING ALPHA-TOCOTRIENOL FROM MIXED TOCOL COMPOSITIONS

JAK Kinase Inhibitor Compounds for Treatment of Respiratory Disease

JAK Kinase Inhibitor Compounds for Treatment of Respiratory Disease

FUSED IMIDAZO-PIPERIDINE JAK INHIBITOR COMPOUND

JAK Kinase Inhibitor Compounds for Treatment of Respiratory Disease